CFO Matt Abernethy projected INGREZZA sales for 2025 to range between $2.5 billion and $2.6 billion, reflecting $250 million growth at the midpoint. He noted increased competitive pressure and payer ...

Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) Q4 2024 Earnings Conference Call February 6, 2025 4:30 PM ET Todd Tushla - Vice President of Investor Relations Kyle Gano - Chief Executive Officer Matt ...

We recently published a list of 10 Stocks That Analysts Are Talking About. In this article, we are going to take a look at ...

What potential does Crenessity have in the CAH market? Crenessity (crinecerfont) addresses a significant unmet need in the treatment of congenital adrenal hyperplasia (CAH). As the first CRF1R ...

President Trump signed an executive order on the first day of his second term beginning the process of withdrawing the U.S. from the World Health Organization. It was among dozens of executive ...

On his first day in office, President Donald Trump signed an executive order withdrawing the U.S. from the World Health Organization (WHO)—a move that experts say makes the U.S. and other ...

Nigeria's women's U-19 cricket team made history by defeating New Zealand by two runs in a rain-affected ICC Women's U-19 T20 World Cup match. Noteworthy performances included Lilian Udeh's ...

The second edition of ICC's Women U-19 World Cup is all set to begin today at the YSD-UKM Cricket Oval stadium in Malaysia with the opening clash between Australia and Scotland. Unlike the Men's ...

On his first day in office, President Donald Trump signed an executive order withdrawing the U.S. from the World Health Organization (WHO)—a move that experts say makes the U.S. and other countries ...

By Claire Moses The U.S.S. Harry S. Truman ... cartoon series that premiered in 1969 and never quite joined the modern world. Lena Schilling, the youngest lawmaker in Brussels, faced a harsh ...

congenital adrenal hyperplasia and other diseases of excess ACTH. All of the company's drug candidates are new chemical entities resulting from in-house drug discovery efforts and are wholly owned ...